NLS Biotech article

Norwegian company AdjuTec’s novel antibiotic resistance breakers may help to facilitate reduced use of antibiotics – and the company is now ready to test its product in humans.

FinVector’s new production unit is set to become one of the world’s largest facilities for manufacturing gene-therapy treatments.

For the second year running, Denmark’s biotech sector is awarded a global top three ranking by Scientific American Worldview and is praised for its generous public sector investment and speedy drug trial application process. Denmark takes the global top three spot in the 2016 Scientific American Worldview Scorecard, assessing countries worldwide according to their biotechnology […]

The Research Council of Norway has awarded NOK 250 million in funding under the new biotechnology initiative on digital life for the establishment of a national centre. Six large-scale Researcher Projects will be carried out under the auspices of the centre, with topics spanning from aquaculture to brain research. Under the strategic initiative “Digital Life […]

The Norwegian Bioindustry Association is one of 20 founding members of the International Council of Biotechnology Associations (ICBA). The goal of the ICBA is to advocate for public policies that support the growth of the biotechnology industry worldwide. Jim Greenwood, president and chief executive officer of the Biotechnology Industry Organization in the U.S., was elected […]

Danish biotech and drug companies are among the best in Europe when it comes to the number of candidate drugs under development, according to a new study. Nordic Life Sciences sector study 2014, by Ernst & Young, concludes that Denmark has the largest pipeline of drugs undergoing clinical trials in Europe relative to its size. Last […]